Literature DB >> 22325671

Epidemiology and the control of disease in China, with emphasis on the Chinese Biobank Study.

L Li1, Y Guo2, Z Chen3, J Chen4, R Peto3.   

Abstract

Similar to many other developing countries, China is facing a double burden of disease as a result of epidemiological transition. Non-communicable diseases (NCDs) represent a major challenge, having an adverse effect on the health of the Chinese population and increasing the economic burden of health care. In today's era of evidence-based medicine and decision making, China, as a developing country, has a lack of local scientific evidence which will affect the effectiveness of NCD prevention and control. As such, and on the basis of decades of cooperation and trust with the University of Oxford, the Chinese Biobank Study [Kadoorie Study of Chronic Disease in China (KSCDC)] was commenced in 2004. KSCDC, an international prospective project, aims to establish the basis of a blood-based health database, using genetic, environmental and lifestyle aspects to investigate and understand the causes, risk factors, pathogenesis, prevalence patterns and trends of major chronic diseases in China (such as stroke, coronary heart disease, cancer, diabetes, hypertension, chronic obstructive pulmonary disease etc.). This study has a duration of 15-20 years, and will provide scientific evidence for strategic planning of NCD prevention and control, and development of new treatment and intervention approaches. In total, approximately 510,000 adults aged 30-79 years have been recruited from the general population in 10 geographically defined regions (five rural and five urban) of China, with differing disease profiles and differing risk exposures. Extensive data collection has been undertaken with questionnaires, physical measurements, and collection and storage of blood samples. KSCDC is a multi-factor, multi-disease, multi-disciplinary large-scale chronic disease epidemiological study, and is also one of the largest long-term blood-based population cohort studies ever conducted in the world. It is worth mentioning that all gene specimens are kept in China, and all associated intellectual property rights are owned by international cooperation groups; this breaks new ground for Chinese and foreign international cooperation. This article describes the study design, baseline description and main results to date. Copyright Â
© 2011 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22325671      PMCID: PMC4340568          DOI: 10.1016/j.puhe.2011.11.012

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


  2 in total

1.  Cohort profile: the Kadoorie Study of Chronic Disease in China (KSCDC).

Authors:  Zhengming Chen; Liming Lee; Junshi Chen; Rory Collins; Fan Wu; Yu Guo; Pamela Linksted; Richard Peto
Journal:  Int J Epidemiol       Date:  2005-08-30       Impact factor: 7.196

2.  Overweight and obesity in China.

Authors:  Yangfeng Wu
Journal:  BMJ       Date:  2006-08-19
  2 in total
  8 in total

Review 1.  The NLRP3 inflammasome and stroke.

Authors:  Yeqing Tong; Zhi-Hong Ding; Fa-Xian Zhan; Li Cai; Xiaoxv Yin; Jin-Lian Ling; Jian-Jun Ye; Shuang-Yi Hou; Zuxun Lu; Zhi-Hong Wang; Jia-Fa Liu
Journal:  Int J Clin Exp Med       Date:  2015-04-15

2.  Opportunities, challenges and expectations management for translating biobank research to precision medicine.

Authors:  Christopher J O'Donnell
Journal:  Eur J Epidemiol       Date:  2020-02-28       Impact factor: 8.082

3.  Polypharmacy in the oldest old (≥80 years of age) patients in China: a cross-sectional study.

Authors:  Xiaoxing Lai; Hongwei Zhu; Xiaopeng Huo; Zheng Li
Journal:  BMC Geriatr       Date:  2018-03-02       Impact factor: 3.921

4.  Unleashing implementation research to accelerate national noncommunicable disease responses.

Authors:  Tea Collins; Svetlana Akselrod; Daria Berlina; Luke N Allen
Journal:  Global Health       Date:  2022-01-24       Impact factor: 4.185

5.  Promoting the adoption of local governmental policy on the reimbursement of chronic disease medicines (PAPMed): study protocol of a field-based cluster randomized trial in rural Nantong, China.

Authors:  Zhengting He; Xin Cao; Duan Zhao; Zemin Tang; Jiayu Zhao; Mariel Beasley; Angela Renne; Lei Liu; Shengjie Zhu; Yuexia Gao; Lijing L Yan
Journal:  Trials       Date:  2022-09-15       Impact factor: 2.728

Review 6.  ELSI practices in genomic research in East Asia: implications for research collaboration and public participation.

Authors:  Go Yoshizawa; Calvin Wai-Loon Ho; Wei Zhu; Chingli Hu; Yoni Syukriani; Ilhak Lee; Hannah Kim; Daniel Fu Chang Tsai; Jusaku Minari; Kazuto Kato
Journal:  Genome Med       Date:  2014-05-30       Impact factor: 11.117

7.  Biobanking across the phenome - at the center of chronic disease research.

Authors:  Medea Imboden; Nicole M Probst-Hensch
Journal:  BMC Public Health       Date:  2013-11-25       Impact factor: 3.295

8.  Investigation of the Relationship Between Chronic Stress and Insulin Resistance in a Chinese Population.

Authors:  Yu-Xiang Yan; Huan-Bo Xiao; Si-Si Wang; Jing Zhao; Yan He; Wei Wang; Jing Dong
Journal:  J Epidemiol       Date:  2016-01-30       Impact factor: 3.211

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.